Checkpoint Therapeutics (CKPT) News Today → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free CKPT Stock Alerts $1.89 0.00 (0.00%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 5, 2024 | globenewswire.comCHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJune 3, 2024 | globenewswire.comCKPT DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPTJune 3, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Checkpoint Therapeutics, Inc. (CKPT)June 3, 2024 | globenewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CheckpointJune 3, 2024 | globenewswire.comCKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!May 31, 2024 | prnewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CheckpointMay 30, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPTMay 30, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitMay 29, 2024 | prnewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPTMay 29, 2024 | msn.comCheckpoint Zoo Documentary Poster Sets Up A 2022 Ukrainian Animal Rescue StoryMay 28, 2024 | markets.businessinsider.comIMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the FirmMay 28, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitMay 27, 2024 | markets.businessinsider.comUPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the FirmMay 26, 2024 | sfgate.com2 Arrested For Driving Under The Influence, 32 Ticketed At CheckpointMay 24, 2024 | prnewswire.comFINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the FirmMay 24, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitMay 23, 2024 | stockhouse.comSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the FirmMay 22, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPTMay 22, 2024 | prnewswire.comROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPTMay 20, 2024 | stockhouse.comUPCOMING CKPT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Checkpoint Therapeutics, Inc. Investors to Join the Class Action Lawsuit!May 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Checkpoint Therapeutics Despite FDA Setback: Solid Clinical Data Fuels Optimism for 2024 Market EntryMay 16, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitMay 16, 2024 | marketbeat.comCheckpoint Therapeutics (NASDAQ:CKPT) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $34.00 target price on shares of Checkpoint Therapeutics in a research note on Thursday.May 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPTMay 15, 2024 | prnewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPTMay 15, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the FirmMay 14, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitMay 13, 2024 | globenewswire.comCheckpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceMay 12, 2024 | finance.yahoo.comCheckpoint Therapeutics First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.89 loss in 1Q 2023)May 10, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitMay 10, 2024 | finanznachrichten.deCheckpoint Therapeutics, Inc: Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesMay 10, 2024 | investorplace.comCKPT Stock Earnings: Checkpoint Therapeutics Misses EPS for Q1 2024May 10, 2024 | globenewswire.comCheckpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesMay 8, 2024 | prnewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPTMay 8, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the FirmMay 7, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the FirmMay 6, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPTMay 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CheckpointMay 2, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitMay 1, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the FirmApril 30, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitApril 30, 2024 | markets.businessinsider.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CheckpointApril 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPTApril 27, 2024 | businesswire.comCKPT SHAREHOLDER ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ...April 27, 2024 | prnewswire.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPTApril 26, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitApril 26, 2024 | businesswire.comCKPT SHAREHOLDER ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CKPTApril 24, 2024 | msn.comDUI Checkpoint to be held in Raleigh CountyApril 24, 2024 | marketbeat.comCheckpoint Therapeutics (NASDAQ:CKPT) Shares Down 1% Checkpoint Therapeutics (NASDAQ:CKPT) Stock Price Down 1%April 23, 2024 | businesswire.comCKPT Shareholders With Large Losses Should Contact Robbins LLP for Information About the Checkpoint Therapeutics, Inc. Class Action Get Checkpoint Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CKPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", CKPT Media Mentions By Week CKPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CKPT News Sentiment▼0.000.76▲Average Medical News Sentiment CKPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CKPT Articles This Week▼52▲CKPT Articles Average Week Get Checkpoint Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CKPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Leap Therapeutics News Today 23andMe News Today Adlai Nortye News Today Enanta Pharmaceuticals News Today Atai Life Sciences News Today Aquestive Therapeutics News Today Immutep News Today Rani Therapeutics News Today MacroGenics News Today Foghorn Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CKPT) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored